Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Central European Journal of Public Health
|
May 23, 2014
Prevalence of cardiovascular risk factors in relation to metabolic syndrome in the Roma population compared with the non-Roma population in the eastern part of Slovakia
Ján Fedacko, Daniel Pella, Peter Jarcuska, et al.
Acta Cardiologica
|
June 1, 2007
Prevalence of obesity, physical inactivity and undernutrition, a triple burden of diseases during transition in a developing economy. The Five City Study Group
Ram B Singh, Daniel Pella, Viola Mechirova, et al.
Learning Health Systems
|
April 23, 2021
European survey on national harmonization in clinical research
Annette Magnin, Valentina Cabral Iversen, Gonzalo Calvo, et al.
Pharmacological Research
|
February 19, 2021
Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)
Maciej Banach, Peter E Penson, Michal Vrablik, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
August 15, 2022
Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
Peter E Penson, Eric Bruckert, David Marais, et al.
Global Heart
|
November 17, 2025
The European Program for Prevention (EPP) - Implementing Proven Preventing Measures Now!
Maciej Banach, Zlatko Fras, Dan Gaita, et al.
Archives of Medical Science : AMS
|
July 14, 2022
The possible role of machine learning in detection of increased cardiovascular risk patients - KSC MR Study (design)
Daniel Pella, Stefan Toth, Jan Paralic, et al.
Progress in Cardiovascular Diseases
|
November 17, 2025
Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP)
Maciej Banach, Peter P Toth, Hyo-Jeong Ahn, et al.
Diabetes Care
|
June 7, 2026
Evolocumab in Patients With High-Risk Diabetes: Results From the VESALIUS-CV Trial
Lawrence A Leiter, Robert P Giugliano, Nicholas A Marston, et al.
Nutrition Reviews
|
September 24, 2017
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
Arrigo F G Cicero, Alessandro Colletti, Gani Bajraktari, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Central European Journal of Public Health
|
May 23, 2014
Prevalence of cardiovascular risk factors in relation to metabolic syndrome in the Roma population compared with the non-Roma population in the eastern part of Slovakia
Ján Fedacko, Daniel Pella, Peter Jarcuska, et al.
Acta Cardiologica
|
June 1, 2007
Prevalence of obesity, physical inactivity and undernutrition, a triple burden of diseases during transition in a developing economy. The Five City Study Group
Ram B Singh, Daniel Pella, Viola Mechirova, et al.
Learning Health Systems
|
April 23, 2021
European survey on national harmonization in clinical research
Annette Magnin, Valentina Cabral Iversen, Gonzalo Calvo, et al.
Pharmacological Research
|
February 19, 2021
Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)
Maciej Banach, Peter E Penson, Michal Vrablik, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
August 15, 2022
Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
Peter E Penson, Eric Bruckert, David Marais, et al.
Global Heart
|
November 17, 2025
The European Program for Prevention (EPP) - Implementing Proven Preventing Measures Now!
Maciej Banach, Zlatko Fras, Dan Gaita, et al.
Archives of Medical Science : AMS
|
July 14, 2022
The possible role of machine learning in detection of increased cardiovascular risk patients - KSC MR Study (design)
Daniel Pella, Stefan Toth, Jan Paralic, et al.
Progress in Cardiovascular Diseases
|
November 17, 2025
Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP)
Maciej Banach, Peter P Toth, Hyo-Jeong Ahn, et al.
Diabetes Care
|
June 7, 2026
Evolocumab in Patients With High-Risk Diabetes: Results From the VESALIUS-CV Trial
Lawrence A Leiter, Robert P Giugliano, Nicholas A Marston, et al.
Nutrition Reviews
|
September 24, 2017
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
Arrigo F G Cicero, Alessandro Colletti, Gani Bajraktari, et al.
Page
of 8